Location History:
- Jadavpur, IN (2020)
- Kolkata, IN (2021)
Company Filing History:
Years Active: 2020-2021
Title: Oindrila Rahaman: Innovator in Immune Modulation
Introduction
Oindrila Rahaman is a prominent inventor based in Kolkata, India. She has made significant contributions to the field of immune modulation through her innovative research and development of novel compounds. With a total of two patents to her name, her work focuses on addressing autoimmune diseases and inflammation.
Latest Patents
Oindrila's latest patents include "Purine based compounds as toll-like receptor 9 antagonist" and "Blocking toll-like receptor 9 signaling with small molecule antagonist." The first patent provides novel purine-based compounds that inhibit signaling through Toll-like receptors, particularly TLR9. These compounds are essential for treating autoimmune diseases and inflammation where TLR9 activation is implicated. The second patent relates to small molecule compounds that inhibit signaling by TLR9, which plays a critical role in the host immune response. These inventions have potential applications as pharmaceutical agents for conditions involving unwanted immune activity.
Career Highlights
Oindrila Rahaman is associated with the Council of Scientific & Industrial Research, where she has been instrumental in advancing research in her field. Her innovative approach and dedication to scientific inquiry have positioned her as a key figure in immune modulation research.
Collaborations
Oindrila collaborates with notable colleagues, including Arindam Talukdar and Dipyaman Ganguly. Their combined expertise enhances the research efforts and contributes to the development of effective therapeutic solutions.
Conclusion
Oindrila Rahaman's contributions to the field of immune modulation through her patents and research are commendable. Her work holds promise for advancing treatments for autoimmune diseases and improving patient outcomes.